Newsletter Subject

Really, Soup Might Help in Osteoarthritis?

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Jun 29, 2024 11:15 AM

Email Preheader Text

Weekly Review Saturday, June 29, 2024 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT CME

[MEDPAGE TODAY]( Weekly Review Saturday, June 29, 2024 [Really, Soup Might Help in Osteoarthritis?]( [Alzheimer's Amyloid Tied to Circadian Disruption Earlier in Life]( [ACIP Makes Changes to Adult RSV Vaccine Recommendations]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care]( [Doc Accused of Stealing Ambulance; Telehealth Nurse Arrested; Heart Surgery Scandal]( [Docs in Abortion Ban States Find Workarounds to Deliver Care]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Dermatologist Debunks Sunscreen Misinformation Making the Rounds on Social Media]( CME SPOTLIGHT [Latest Clinical Evidence in Adult Diffuse Low-Grade Glioma]( [Real-World Analysis Identifies Meds Tied to Higher Risk of Liver Injury]( [A Closer Look at Medetomidine and Its 'Unusual' Patient Presentations]( [Should Doctors Treat Family and Friends, Even If Ethics Codes Say Otherwise?]( CME SPOTLIGHT [Employing Collaborative Care Strategies for the Management of Pediatric Patients With Hodgkin Lymphoma]( [Novel GLP-1/Glucagon Drug Promising for Weight Loss]( [Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic Stroke]( [Infant Deaths Increased After Texas Ban on Abortion in Early Pregnancy]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [AI Helps Predict Dementia Using Speech Patterns]( [More Than 1 in 4 Seniors Have Asymptomatic Valve Disease]( [Blood Panel Predicts Parkinson's; Transgender Neurologic Care; Rare COVID Case]( CME SPOTLIGHT [The Evolving Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: Integrating Biomarkers and Novel Treatment Approaches]( [The Power of 'Enough-ness' in Medicine]( [First GLP-1 Generic Launched; 5:2 Intermittent Fasting Win; WHO's Ozempic Warning]( [Oral Ketamine for Depression; ADHD Video Game Cleared; Narcolepsy Drug OK'd for Kids]( CME SPOTLIGHT [PARP Prodigy: Mastering Metastatic Castration-Resistant Prostate Cancer]( [CDC Advisors Back Updated COVID, Flu Vaccines for the Fall]( [More Evidence That Flu Is Linked to Heart Attacks]( [What Should Be Done About Long-Term Care?]( CME SPOTLIGHT [Optimizing Co-management of Patients With Upper GI Cancers (GC/GEJC/EAC) Using a Tumor Board Model]( [New Treatment Approved for Chronic Inflammatory Demyelinating Polyneuropathy]( [U.S. Hospitals Prone to Cyberattacks Like the One at Ascension, Experts Say]( [Cardiovascular Risks Established in Childhood Don't Just Go Away]( CME SPOTLIGHT [Novel and Emerging Combination Approaches for Advanced/Metastatic RCC]( ['The Data Do Not Even Exist': What We Heard This Week]( [Biden, Trump Spar Over Abortion, COVID in Debate and Face Questions on Their Age]( [Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials]( [Fenofibrate Slows Diabetic Retinopathy Progression]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2024-06-29&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

02/07/2024

Sent On

02/07/2024

Sent On

02/07/2024

Sent On

01/07/2024

Sent On

01/07/2024

Sent On

01/07/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.